Petros Pharmaceuticals (PTPI) Revenue & Revenue Breakdown
Petros Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$5.82B
Latest Revenue (Q)
$1.42M
Main Segment (Y)
Medical Devices
Main Geography (Y)
United States
Petros Pharmaceuticals Revenue by Period
Petros Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $5.82B | 97068.48% |
| 2022-12-31 | $5.99M | -23.29% |
| 2021-12-31 | $7.81M | -18.29% |
| 2020-12-31 | $9.56M | -38.63% |
| 2019-12-31 | $15.58M | - |
Petros Pharmaceuticals generated $5.82B in revenue during NA 2023, up 97068.48% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Petros Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $1.42M | 2.35% |
| 2024-03-31 | $1.39M | -481.28% |
| 2023-12-31 | $-364.25K | -121.75% |
| 2023-09-30 | $1.67M | -16.02% |
| 2023-06-30 | $1.99M | -20.81% |
| 2023-03-31 | $2.52M | 215.50% |
| 2022-12-31 | $798.10K | -154.75% |
| 2022-09-30 | $-1.46M | -134.82% |
| 2022-06-30 | $4.19M | 69.83% |
| 2022-03-31 | $2.47M | -384.28% |
| 2021-12-31 | $-867.16K | -140.42% |
| 2021-09-30 | $2.15M | -12.71% |
| 2021-06-30 | $2.46M | -39.70% |
| 2021-03-31 | $4.08M | 39.13% |
| 2020-12-31 | $2.93M | -15.45% |
| 2020-09-30 | $3.46M | 152.24% |
| 2020-06-30 | $1.37M | -23.35% |
| 2020-03-31 | $1.79M | -14.58% |
| 2019-12-31 | $2.10M | -51.97% |
| 2019-09-30 | $4.37M | 8.59% |
| 2019-06-30 | $4.02M | -20.97% |
| 2019-03-31 | $5.09M | - |
Petros Pharmaceuticals generated $1.42M in revenue during Q2 2024, up 2.35% compared to the previous quarter, and up 56.45% compared to the same period a year ago.
Petros Pharmaceuticals Revenue Breakdown
Petros Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| Medical Devices | $3.54M | - | - |
| Medical Device Sales | - | $3.26M | $3.21M |
| Prescription Medication Sales | - | - | $4.61M |
Petros Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Medical Devices (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical Devices | $806.45K | $775.71K | $2.52M | $1.01M | $682.90K | - | - | - | - | - | - | - |
| Medical Device Sales | - | - | - | - | $779.77K | $854.34K | $940.40K | $755.55K | $767.88K | $807.83K | $874.96K | - |
| Prescription Medication Sales | - | - | - | - | - | - | $3.33M | $1.52M | $-1.62M | $1.38M | $1.65M | $3.20M |
Petros Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Medical Devices (100.00%).
Petros Pharmaceuticals Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| International | $1.30M | - | - |
| United States | $4.53M | $4.80M | $6.57M |
| Non Us | - | $1.19M | - |
Petros Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 23: United States (77.75%), and International (22.25%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.11M | $1.18M | $2.37M | $2.16M | $538.96K | $-1.65M | $3.86M | $2.05M | $-1.18M | - | - | - |
| International | $316.04K | $209.96K | - | - | - | - | - | - | - | - | - | - |
| Medical Devices | - | - | - | $1.01M | - | - | - | - | - | - | - | - |
| Non Us | - | - | - | - | $259.14K | $268.86K | $371.08K | - | - | - | - | - |
| UNITED STATES | - | - | - | - | - | - | - | - | - | $1.86M | - | - |
| U | - | - | - | - | - | - | - | - | - | - | $2.19M | $3.70M |
Petros Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Jun 24: United States (77.77%), and International (22.23%).
Petros Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PTPI | Petros Pharmaceuticals | $5.82B | $1.42M |
| LFCR | Lifecore Biomedical | $128.26M | $24.70M |
| ALIM | Alimera Sciences | $80.75M | $23.01M |
| SBFM | Sunshine Biopharma | $39.85M | $9.30M |
| CPIX | Cumberland Pharmaceuticals | $39.55M | $9.09M |
| TKNO | Alpha Teknova | $36.68M | $9.58M |
| AGRX | Agile Therapeutics | $19.59M | $5.58M |
| SNOA | Sonoma Pharmaceuticals | $12.73M | $3.39M |
| GHSI | Guardion Health Sciences | $12.25M | $36.35K |
| EVOK | Evoke Pharma | $5.18M | $2.65M |
| ADMP | Adamis Pharmaceuticals | $4.76M | $9.06M |
| AKAN | Akanda | $2.16M | $762.61K |
| SXTC | China SXT Pharmaceuticals | $1.97M | $939.58K |
| LSDI | Lucy Scientific Discovery | $7.05K | $9.68K |
| SHPH | Shuttle Pharmaceuticals | - | - |
| PRFX | PainReform | - | - |